Mental illness and menopause: A patient and family perspective

Journal of Gender-Specific Medicine

Volumn 6, Issue 2, 2003, Pages 31-34

  Sajatovic, Martha ^a   Rosenthal, Miriam B ^b   Solomom Plax, Miriam ^c   Meyer, Mindy L ^c   Bingham, C Raymond ^d  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NAMI Metro Cleveland   (United States)

^d UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ANXIETY DISORDER; ARTICLE; BIPOLAR DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE EXACERBATION; EMOTION; FAMILY; FEMALE; HEALTH SURVEY; HUMAN; LIFE EVENT; MENOPAUSE; MENTAL DISEASE; PERSONALITY DISORDER; QUESTIONNAIRE; SCHIZOPHRENIA; SYMPTOMATOLOGY;

BIPOLAR DISORDER; DEPRESSION; EMOTIONS; FEMALE; HUMANS; LIFE CHANGE EVENTS; MENOPAUSE; MENTALLY ILL PERSONS; MIDDLE AGED;

EID: 0038150600     PISSN: 15237036     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Salokangas RK. Gender and the use of neuroleptics in schizophrenia: Further testing of the oestrogen hypothesis. Schizophr Res 1995;15(1):7-16.
2. Sajatovic M, Donenwirth K, Sultana D, et al. Admissions, length of stay, and medication use among women in an acute care state psychiatric facility. Psychiatr Serv 2000;51(10):1278-1281.
3. Becker D, Lomranz J, Pines A, et al. Psychological distress around menopause. Psychosomatics 2001;42(3):252-257.
4. DeBattista C, Smith DL, Schatzberg AF. Modulation of monoamine neurotransmitters by estrogen: Clinical implications. In: Leibenluft E, ed. Gender Differences in Mood and Anxiety Disorders. Washington, DC: American Psychiatric Press, Inc.; 1999.
5. Birge SJ, McEwen BS, Wise PM. Effects of Estrogen Deficiency in Brain Function. Post-Graduate Medicine Special Report. An Update on the Effects of SERMs on Women's Health. Minneapolis, MN: McGraw-Hill Healthcare Information Group, Inc.; 2001.
6. Schmidt PJ, Roza CA, Rubinm DR. Psychiatric disorders during the perimenopause. Baillieres Clinical Psychiatry 1996;2:4.
7. Seeman MV. Narratives of twenty to thirty year outcomes in schizophrenia. Psychiatry 1998:61(3);249-261.
8. Hafner H, an der Heiden W. Epidemiology of schizophrenia. Can J Psychiatry 1997;42(2):139-151.
9. Blehar MC, DePaulo JR, Gershon ES, et al. Women with bipolar disorder: Findings from the NIMH Genetics Initiative Sample. Psychopharmacol Bull 1998;34(3):239-243.
10. Isimaru-Tseng TV. Evaluation of late onset bipolar illness during menopause. Hawaii Med J 2000;59(2):51-53.